Table 3 Locoregional recurrences in patients who underwent 3D-conformal radiotherapy
Localization | Age/sex | Histology | Time to recurrence | Dose in recurrence region |
|---|---|---|---|---|
(Months) | (Gray) | |||
In-field recurrence | 61/m | Epithelioid | 21 | 50 |
In-field recurrence | 68/m | Biphasic | 16 | 36 |
In-field recurrence | 68/m | Epithelioid | 13 | 30 |
In-field recurrence | 65/m | Biphasic | 19 | 56 |
In-field recurrence | 65/m | Biphasic | 16 | 50 |
In-field recurrence | 50/m | Epithelioid | 29 | 48 |
In-field recurrence | 55/m | Biphasic | 8 | 50 |
In-field recurrence | 66/m | Biphasic | 20 | 36, 501 |
In-field recurrence | 68/m | Epithelioid | 11 | 32–43, 46–501 |
In-field recurrence | 58/m | Epithelioid | 9 | 50 |
In-field recurrence | 58/m | Epithelioid | 11 | 50 |
In-field recurrence | 65/m | Biphasic | 19 | 30 |
Marginal miss recurrence | 55/m | Epithelioid | 19 | 18 |
Regional recurrence | 62/m | Epithelioid | 13 | Not available |
Unknown | 56/m | Epithelioid | 13 | Not available |